<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We reviewed the medical history of 26 women with <z:e sem="disease" ids="C1337013" disease_type="Neoplastic Process" abbrv="">differentiated thyroid cancer</z:e> who became pregnant after receiving therapeutic doses of radioactive <z:chebi fb="60" ids="24859">iodine</z:chebi> (131I) in order to document the possibility of a greater risk for disorders in these pregnancies </plain></SENT>
<SENT sid="1" pm="."><plain>There were a total of 39 pregnancies, 6 of which occurred during the first year after therapy </plain></SENT>
<SENT sid="2" pm="."><plain>In 3 cases the following anomalies were encountered: a male suffering <z:mp ids='MP_0004027'>Trisomy</z:mp> 18 (<z:e sem="disease" ids="C0152096" disease_type="Disease or Syndrome" abbrv="">Edward's syndrome</z:e>), a female with constitutional <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, and a male with a <z:hpo ids='HP_0001385'>congenital hip dysplasia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Of the 33 pregnancies that occurred after the first year post-therapy, there were 2 <z:hpo ids='HP_0005268'>spontaneous abortions</z:hpo> and a male effected by <z:hpo ids='HP_0000071'>ureteral stenosis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Based on these data, although it cannot be confirmed that these <z:e sem="disease" ids="C0242354" disease_type="Disease or Syndrome" abbrv="">congenital disorders</z:e> are due to the 131I therapy, we recommend that pregnancy be avoided for the first year after therapy </plain></SENT>
</text></document>